Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of ACC006 plus nab-paclitaxel and carboplatin in advanced squamous non-small cell lung cancer
ChiCTR2000035558Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ACC006 in Pulmonary squamous cell carcinoma (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Progression-free survival. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
ACC006
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR2000035558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035558.